Livongo Health participates in a conference call with Morgan Stanley » 16:3904/0604/06/20
Merit Medical receives two additional FDA Breakthrough Device designations » 09:3404/0604/06/20
Merit Medical Systems…
Merit Medical Systems announced that it has been granted two additional Breakthrough Device designations by the U.S. Food and Drug Administration for the Merit WRAPSODY Endovascular Stent Graft System. The WRAPSODY system is a flexible, self-expanding endoprosthesis. The new indications for use include treatment of stenosis or occlusion within the dialysis outflow circuit, including stenosis or occlusion within the peripheral veins in the arm of Arteriovenous Fistula patients, and within the thoracic central veins, up to the superior vena cava, in Arteriovenous Graft patents. If the system is approved by the FDA for these indications, Merit believes the expanded indications will increase patient access to this life-saving technology.
Thermo Fisher withdraws FY20 guidance provided on January 30 » 08:3804/0604/06/20
Thermo Fisher announced…
Myriad Genetics receives reinmbursement for BRACAnalysis system in Japan » 07:1904/0604/06/20
Myriad Genetics announced…
Myriad Genetics announced that it has received reimbursement and launched the BRACAnalysis Diagnostic System in Japan to help physicians determine which people affected with breast and ovarian cancer have Hereditary Breast and Ovarian Cancer syndrome and qualify for additional diagnostic and medical management. BRACAnalysis previously was approved by Japan's Ministry of Health, Labour and Welfare in November 2019 for this indication. Effective immediately, physicians can order the BRACAnalysis test for affected patients who meet the genetic testing criteria defined by JOHBOC including Presence of BRCA1 or BRCA2 pathogenic mutations in family members. Individual has breast cancer and meets any of the following: Breast cancer under 45, Triple-negative breast cancer aged 60 or younger, Two or more primary breast cancers, One or more third-degree relatives with breast or ovarian cancer. Individual has ovarian, fallopian tube, and peritoneal cancers. Male breast cancer. Tumor tissue profiling tests that suggest retention of BRCA1 or BRCA2 germline pathogenic mutation if cancer eligibility criteria for companion diagnosis for PARP inhibitor are met.
Fly Intel: Top five weekend stock stories » 20:0904/0504/05/20
GILD, BA, FB, TWTR, GOOG, GOOGL, UAL, CMCSA, CMCSK, T, VZ, ABT, CVX, HRL, JNJ, KMB, MDT, PG, TROW
Catch up on the…
Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Gilead Sciences (GILD) said it is donating 1.5M doses of its experimental anti-coronavirus drug remdesivir, which could treat 140,000 patients. In an open letter, Chairman and CEO Daniel O'Day said that the drug will be offered for compassionate use, expanded access and clinical trials, and will treat patients with severe symptoms. "Our existing supply, including finished product ready for distribution as well as investigational medicine in the final stages of production, amounts to 1.5 million individual doses. Depending on the optimal duration of treatment, which is something we are studying in clinical trials, this supply could equate to well over 140,000 treatment courses for patients. [...] Gilead is providing the entirety of this existing supply at no cost, to treat patients with the most severe symptoms of COVID-19. The 1.5 million individual doses are available for compassionate use, expanded access and clinical trials and will be donated for broader distribution following any potential future regulatory authorizations. These doses are for treating patients with severe symptoms, through daily intravenous infusions in a hospital setting. Having a potential treatment in our hands comes with significant responsibility." 2. Boeing (BA) announced that it is extending the temporary suspension of production operations at all Puget Sound area and Moses Lake sites until further notice. "These actions are being taken in light of the company's continuing focus on the health and safety of employees, current assessment of the spread of COVID-19 in Washington state, the reliability of the supply chain and additional recommendations from government health authorities," the plane maker said in a statement Sunday night. 3. Across the media landscape, advertising is disappearing, one more casualty of the global economic shutdown, and new technology won't be a savior as this is an equal-opportunity problem across print, TV, digital, radio, and outdoor advertising, Eric Savitz wrote in this week's edition of Barron's. Even the most prominent ad buyers lack reasons, and often the means, to buy ads, the author notes, while many of the small and medium-size businesses that buy online ads are struggling to stay solvent. Both Facebook (FB) and Twitter (TWTR) have already warned that they will take a hit from the downturn, and Alphabet's Google (GOOGL) no doubt is seeing the same effects, but so far hasn't discussed the matter, the publication adds. 4. United Airlines (UAL) is cutting nearly 90% of its New York-area flying, as public health officials predicted that the city will reach the peak of its novel coronavirus outbreak in the coming days, The Wall Street Journal's Alison Sider reported. The airline said the reductions set to remain in place for at least three weeks will mean substantially fewer employees will need to show up each day, though workers will continue to receive pay and benefits, the author noted. 5. Comcast (CMCSA), AT&T (T), Verizon (VZ), Abbott Laboratories (ABT), Chevron (CVX), Hormel Foods (HRL), Johnson & Johnson (JNJ), Kimberly-Clark (KMB), Medtronic (MDT), Procter & Gamble (PG), and T. Rowe Price (TROW) saw positive mentions in this week's edition of Barron's.
Amazon, test makers in contact for potential employees' screenings, Reuters says » 15:5204/0504/05/20
AMZN, ABT, TMO
Amazon (AMZN) has been in…
Amazon (AMZN) has been in contact with the CEOs of two coronavirus test makers as it considers how to screen its staff and reduce the risk of infection at its warehouses, Reuters' Jeffrey Dastin and Krystal Hu report, citing internal meeting notes. The chief executives of Abbott Laboratories (ABT) and Thermo Fisher Scientific (TMO) have told Amazon they would like to work with the e-commerce company, though the U.S. government is taking up all of their testing capacity at present, the notes said. Reference Link
J&J, Chevron among names with safe dividends for now, Barron's says » 10:0404/0404/04/20
TROW, PG, MDT, KMB, JNJ, HRL, CVX, ABT
Among the 64 S&P 500…
Among the 64 S&P 500 Dividend Aristocrats, the dividends of Abbott Laboratories (ABT), Chevron (CVX), Hormel Foods (HRL), Johnson & Johnson (JNJ), Kimberly-Clark (KMB), Medtronic (MDT), Procter & Gamble (PG), and T. Rowe Price (TROW) look safe for now, thanks in part to relatively low debt loads, Lawrence Strauss writes in this week's editions of Barron's. Reference Link
Livongo Health contract win validates product offerings, says Canaccord » 09:0104/0304/03/20
Canaccord analyst Richard…
Canaccord analyst Richard Close noted Livongo Health announced Kaiser Permanente has added its tele-behavioral health service MyStrength to most of its health plan's regions.The analyst views this as a significant validation of the company's service and provides confidence that its chronic care platform and remote monitoring services should experience solid demand by employers and health plans. Close maintained his Buy rating and $46 price target on Livongo Health shares.
Kaiser Permanente adding Livongo's digital mental health app myStrength » 08:5304/0304/03/20
Kaiser Permanente announced that "as part of its commitment to offer members innovative ways to promote personal health and wellness, particularly during increasing levels of stress and anxiety," the health system is is adding the digital mental health app myStrength to its portfolio of self-care tips and tools. Kaiser Permanente members in most regions can download the app and support their mental health and wellness 24/7 using their smartphone, computer, or tablet at no cost and without a referral, the health group announced. myStrength is the behavioral health solution within Livongo's integrated chronic condition management platform. "Livongo is proud to partner withKaiser Permanenteto offer myStrength's breadth of behavioral health tools, including strategies to manage heightened stress, tips for parenting during challenging times, ideas to manage social isolation, and other information for emotional support," said Livongo president Jennifer Schneider. Reference Link
Trump statement on order under the Defense Production Act to make ventilators » 17:0904/0204/02/20
GE, HRC, MDT, RMD
"Today, I have…
"Today, I have issued an order under the Defense Production Act to more fully ensure that domestic manufacturers can produce ventilators needed to save American lives. My order to the Secretary of Health and Human Services and the Secretary of Homeland Security will help domestic manufacturers like General Electric, Hill-Rom, Medtronic, ResMed, Royal Philips, and Vyaire Medical secure the supplies they need to build ventilators needed to defeat the virus. I am grateful to these and other domestic manufacturers for ramping up their production of ventilators during this difficult time. Today's order will save lives by removing obstacles in the supply chain that threaten the rapid production of ventilators." Companies mentioned in the order include General Electric (GE), Hill-Rom (HRC), Medtronic (MDT) ResMed (RMD). Reference Link